RSS Feed     Twitter     Facebook

Posts Tagged ‘vaccine’

Human trials for first genetically engineered malaria vaccine to begin soon

A team of Australian scientists, in collaboration with researchers from the US, Japan and Canada, has created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease.
The vaccine will be trailed in humans from early next year at the Walter Reed Army Institute of Research in [...]

Test case

By Nick Bryant
BBC News, Sydney

An Australian receives a swine flu vaccination in Adelaide - 24 July 2009

Australia is currently living through what the northern hemisphere will soon have to confront: a winter with swine flu.

Public health officials in countries like the UK and US are therefore looking upon Australia as a global case study, and seeing what lessons they can glean from the country’s handling of the pandemic.

Distance offered no protection for this far-flung country, and swine flu reached its shores in early May.

Since then, more than 40 people have died and more than 16,000 have been infected. There has been no sense of public panic, despite the fact that Melbourne for a time was dubbed the "swine flu capital of the world", the city with the highest concentration of cases.

With New Zealand hit first, Australia had a few crucial weeks to refine its response.

It prepared public information adverts, warning people to be careful to wash their hands and quickly rolled out thermal-imaging cameras at international airports to try to identify air travellers arriving with the virus.

If there was a vulnerability, it was at the ports. For a time, cruise passengers set foot in the country without being checked.

Although a swimming meet was cancelled in June, sports fixtures have not been disrupted and neither have other public gatherings.

People are going around wearing protective masks, and the swine flu outbreak has not even dominated the headlines in recent times, although it has received extensive coverage.

Risk to Aborigines

Some affected schools have been shut, because Australia has realised that children are the so-called "super-spreaders" of H1N1.

Therein lies a lesson for the northern hemisphere, according to Professor Raina MacIntyre, from the University of New South Wales.

"Shutting schools is probably the key non-pharmaceuticals intervention and social distancing intervention that can have an impact," he said.

"We’ve had controversy here about things like banning sports fixtures and mass gatherings, and so on. But they have less of an impact than school closures because children are one of the key reservoirs of infection and transmission."

Australia’s indigenous population is at particular risk from swine flu

World response to swine flu crisis

Correspondents’ round-up

Aboriginal boy outside shop in outback town of Wadeye in the Northern Terrritory, Australia - 1 June 2009

The vulnerable groups in Australia are similar to those elsewhere, she says: the young, pregnant women and the obese.

But indigenous Australians have also been at particular risk, partly because so many Aborigines tend to suffer from underlying medical conditions, and the provision of healthcare is not as good in the Outback communities where many of them live.

Then there is the problem of poor living conditions, which can accelerate the spread of the disease.

Last week, Alf Lacey, the Mayor of Palm Island, off the Queensland coast, described how 15 residents were living in a three-bedroom house.

It is thought 400 Palm Islanders have been infected out of a population of 3,500.

Last week, a pregnant woman suffering from swine flu was airlifted off the island. She lost her unborn child.

Vaccine trials

Elsewhere in Australia, intensive care units have come under a lot of pressure, and there has been a heightened demand for last-resort cardiac bypass machines which oxygenate the blood in cases where the lungs are particularly badly diseased or damaged.

One hospital in Sydney reported that it normally treats about five patients a year using these ECMO machines, as they are called. In the past few weeks alone, it has treated double that number.

Last week, Australia started human trials of a swine flu vaccine in Melbourne and Adelaide, the first in the world.

It is hoped that the vaccine will be available by October, and the Australian government has already ordered 21 million doses. The companies developing the vaccine are also looking to sell it abroad.

By then, it will be springtime in Australia. But one of the lessons this country has learnt from the northern hemisphere is that swine flu can spread even at the height of summer.</p


This article is from the BBC News website. © British Broadcasting Corporation, The BBC is not responsible for the content of external internet sites.

Fast-tracked flu vaccine ‘will be safe’

• EU accelerates approval process for treatment
• WHO chief warns of dangers of untested jabs

The World Health Organisation has raised concerns about the fast-track production of the swine flu vaccine in Europe, where the treatment is due to be made available at least two months earlier than in the US. Britain is expected to be the first country in Europe to provide the vaccine, with the first of 132 million ordered doses due to be administered next month.

The European Medicines Agency (EMA), the drug regulatory body for the EU, is accelerating the approval process for the vaccine, and countries including Britain, Greece, France and Sweden plan to start using it as soon as it is cleared. The most vulnerable groups, such as pregnant women and young children, will be given priority.

To ensure the vaccine is available as soon as possible, the EMA is allowing companies to bypass large-scale human trials. Amid concerns about bird flu several years ago, the EMA designed a protocol to fast-track the approval of a vaccine. It let companies submit data for a “mock-up” vaccine, using H5N1 avian flu. The idea was to do most of the testing before a pandemic, so that when it hit, the drug companies could insert the pandemic virus into the vaccine.

When the first doses are ready, the EMA will approve them largely based on data from the bird flu vaccine, since both will have the same basic ingredients. The agency will then require regular reporting of the vaccine’s effects as it is being administered, monitoring that is normally done beforehand.

The US government is taking a more cautious approach, calling for several thousand volunteers to be injected with the vaccine in tests beginning in August to assess its safety. Officials say the results should be ready in time for the vaccination programme to roll out in October.

But some US officials believe the European approach is the best option. “The consequences of not having a vaccine if this virus gets worse are very high,” said Leonard Marcus, a public health expert at Harvard University. “If [regulatory authorities] took all the time that was necessary to make sure there are no side effects, ironically, in the effort to save a few lives, many lives could be lost.”

An EMA spokesman said: “Everybody is doing the best they can in a situation which is far from ideal. With the winter flu season approaching, we need to make sure the vaccine is available.”

Dr Keiji Fukuda, the WHO’s flu chief, warned about the potential dangers of untested vaccines. “There are certain areas where you can make economies, perhaps, but certain areas where you simply do not try to make any economies,” he told Associated Press.

The Department of Health said it was “extremely irresponsible” to suggest the UK would use an unsafe vaccine. A spokesman said: “In preparing for a pandemic, appropriate trials to assess safety and the immune responses have been carried out on vaccines very similar to the swine flu vaccine. The vaccines have been shown to have a good safety profile. Over 40,000 doses of the vaccines which the swine flu vaccines are based on have been given without any safety concerns.”

Professor Steve Field, chairman of the Royal College of GPs, added: “I’m sure the vaccine programme won’t be allowed to commence until adequate safety checks have been carried out.”

Earlier this month the head of the WHO, Dr Margaret Chan, said that while a vaccine might be produced next month the clinical trial data to ensure it was safe would not be available for a further two to three months.

Pharmaceutical companies, including GlaxoSmithKline, which is producing the vaccine for Britain, insist they will be able to start shipping the first batches of vaccine before then.

Meanwhile the House of Lords science and technology committee is expected to accuse ministers of failing to keep their promise to set up a flu helpline by April and question the conflicting advice given to the public, in particular to vulnerable groups such as expectant mothers.

guardian.co.uk © Guardian News & Media Limited 2009 | Use of this content is subject to our Terms & Conditions | More Feeds


US gears for huge swine flu vaccination push

Anxiously eyeing the approach of winter, US health officials are urgently gearing up for a huge vaccine campaign hoping Americans will swing behind  efforts to protect them from swine flu .  "Ultimately, the number of people that we hope will be vaccinated before the fall winter wave of H1N1Anxiously eyeing the approach of winter, US health officials are urgently gearing up for a huge vaccine campaign hoping Americans will swing behind efforts to protect them from swine flu . “Ultimately, the number of people that we hope will be vaccinated before the fall winter wave of H1N1

Europe fast-tracking swine flu vaccine

LONDON (AP) — In a drive to inoculate people against swine flu before winter, many European governments say they will fast-track the testing of a new flu vaccine, arousing concern among some experts about safety issues and proper vaccine doses.
The European Medicines Agency, the EU’s top drug regulatory body, is accelerating the approval process for [...]

Swine flu ‘reaches 160 countries’

Keiji Fukuda. WHO Assistant Director in Geneva (3 July 2009)

The swine flu virus has reached 160 countries and could infect two billion people within the next two years, the World Health Organization has said.

A senior WHO official, Keiji Fukuda, said the virus was still in its early stages and would continue to spread for some time.

Mr Fukuda said work on a vaccine was intensifying but safety could not be compromised by rushing the process.

The virus is thought to have killed almost 800 people in recent months.

Mr Fukuda, the WHO’s Assistant Director General for Health Security, said the agency had been reporting only laboratory-confirmed cases, but that this was always going to be "only a subset of the total number of cases".

"Even if we have hundreds of thousands of cases or a few millions of cases, we’re relatively early in the pandemic," he told the Associated Press news agency.

"One of the things that is relatively clear is that we will continue to see spread of the virus; even though we are now three to four months into the pandemic, this is still pretty early into the overall period," he said.

Mr Fukuda said the WHO estimates two billion people, one third of the global population, could eventually be infected.

He said the figure was a reasonable prediction, based on analysis of previous pandemics, but that it was "really impossible to predict what the future will hold".

Pregnancy risk

World response to swine flu crisis

Send us your comments

A man and woman wearing facemasks at a hospital in Rio de Janiero, Brazil (23 July 2009)

Mr Fukuda said officials and drug manufacturers were investigating how to speed up the process of developing a vaccine against the H1N1 swine flu strain.

But he said there could be no doubt over the safety and efficacy of the drug before it was publicly distributed.

"There is always a balance in this sort of situation. You of course want to get out vaccine and as much vaccine as possible, as quickly as possible. On the other hand there are certain things which cannot be compromised," he said.

"There are certain areas where you can make economies, perhaps, but certain areas where you simply do not try to make any economies."

The WHO says that in most affected countries, the majority of cases appear to be occurring in young people, around the ages of 12 to 17, although some reports suggest it is mainly older people who have required hospital treatment.

The organisation also said there was "accumulating evidence suggesting pregnant women are at higher risk of more severe disease".

But Mr Fukuda said the WHO "certainly has no recommendations on whether women should try to have children now".</p


This article is from the BBC News website. © British Broadcasting Corporation, The BBC is not responsible for the content of external internet sites.

Swine flu vaccine to be manufactured three companies

The Centre has granted licence to three pharmaceutical companies to manufacture swine flu vaccine.
According to sources, these companies will contact the World Health Organisation for acquiring seeds.
A committee has been constituted to keep watch on the process of aquiring the seeds and manufacturing of vaccine. It will be headed by Director General of the Indian [...]

Vi typhoid vaccine protects young Indian children

A currently available and yet unused typhoid vaccine has been found effective in protecting young children in India, according to researchers.
The research team from National Institute of Cholera and Enteric Diseases (NICED) in Kolkata, India and International Vaccine Institute (IVI), Korea showed that vaccine Vi polysaccharide is ideally suited to use in developing countries [...]

Glaxo predicts swine flu gold rush

Britain’s biggest pharmaceutical company is preparing to sell £3bn worth of swine flu drugs this year, it emerged today.

GlaxoSmithKline revealed its vaccine, one of the world’s first, could be available by September after the UK government placed advance orders for 60m doses.

It also disclosed that international governments were stockpiling large supplies of GSK’s anti-viral treatment Relenza, which can relieve swine flu symptoms.

Worldwide sales from the two drugs are expected to reach £3bn by January, but the company rejected claims it was exploiting the pandemic – stressing that profits would be much lower once development costs were taken into account.

It also said poorer nations would receive the vaccine for free with 50m doses to be donated to the World Health Organisation. More could follow, depending on demand.

The chief executive, Andrew Witty, said the company had been preparing for a pandemic for the last three-and-a-half years and had spent more than £1bn to ensure its factories could crank up production at short notice. “We don’t know how big this deal is going to be, but no-one can say we aren’t ready,” said Witty. “We are working flat out with governments around the world to come up with a solution.”

GlaxoSmithKline has also developed an anti-viral face mask, which is expected to be used by people such as “front line health workers.”

Swine flu is thought to have led to the deaths of 31 people in Britain so far and further details of its rapid spread are due to be released by the NHS tomorrow.

The world’s first human trials of a swine flu vaccine have begun in Australia, drug company officials said, as the global death toll from the virus rose to 700.

Two biotechnology companies have started injecting adult volunteers in the southern city of Adelaide.

In a sign of how quickly GSK is working to make sure a vaccine is available from September, the company said that “clinical trials will be limited, due to the need to provide the vaccine to governments as quickly as possible.

“Additional studies will therefore be required and conducted after the vaccine is made available.”

guardian.co.uk © Guardian News & Media Limited 2009 | Use of this content is subject to our Terms & Conditions | More Feeds


Human swine flu vaccine trials begin

• Two biotechnology companies start injecting adult volunteers with swine flu vaccine
• Experts say it could be two months before they can verify vaccine’s effectiveness

The world’s first human trials of a swine flu vaccine have begun in Australia, drug company officials said today, as the global death toll from the virus rose to 700.

Two biotechnology companies have started injecting adult volunteers in the southern city of Adelaide. CSL, a Melbourne company, has 240 people in its seven-month trial starting today. Vaxine, from Adelaide, began trials on Monday with 300 people.

At least 41 people have died in swine flu-related illness in Australia, now well into its winter flu season.

“We’re in the southern hemisphere, and that is where the problem is right now,” Vaxine’s research director, Nikolai Petrovsky, said. “The demand was here yesterday. We’re right in the middle of a surge of swine flu cases where perhaps the US won’t have to worry about it as much until their flu season hits, in six months.”

Australia had confirmed 14,703 cases of swine flu, while the number of deaths from the virus globally is more than 700, according to the World Health Organisation, which recently stopped counting the number of cases worldwide. A surge in cases is predicted in September and October, when students and workers in the northern hemisphere return from summer vacation.

The Australian government has already ordered 21m doses of CSL’s vaccine for use in Australia, should it be proved to work.

“We have a specific vaccine that we believe will be able to protect millions of people against this new H1N1 flu,” Andrew Cuthbertson, CSL’s director of research and development, told reporters. He called swine flu “a novel strain of influenza”, and said the trial would determine the dose and schedule of the vaccination.

Petrovsky said it would be six to eight weeks before results would verify whether a vaccine was effective.

“There is no guarantee any of these vaccines will work,” he said. “Swine flu is a very peculiar beast. It is a very different virus that we’re dealing with. But we are hopeful.”

Medical experts warned against rushing the vaccines through trials.

“I think it’s important for the public to know that they’re going to get a safe and effective vaccine,” Andrew Pesce, president of the Australian Medical Association, told Sky News television. “No one will give anybody brownie points for putting out a vaccine that didn’t work or caused harm.”

In Britain, the UK’s health protection agency (HPA) estimates there were 55,000 new cases of swine flu in England the week before last, including people visiting GPs and those who are looking after themselves at home.

The British pharmaceutical giant, GlaxoSmithKline, said in May it had agreed to supply nearly 130m doses of the swine flu vaccine to the UK, France, Belgium and Finland. It also said it would donate 50m doses to developing countries. The vaccine is expected to come before the end of the year.

Glaxo is one of several companies charged with producing a vaccine for H1N1 after the outbreak of the virus was declared a pandemic last month.

guardian.co.uk © Guardian News & Media Limited 2009 | Use of this content is subject to our Terms & Conditions | More Feeds


Australia starts swine flu vaccine trial as world toll leaps

Australia on Wednesday began human trials for a swine flu vaccine as concerns grew over the disease after the global death toll leapt suddenly past 700.  Some 240 adults and 400 children are involved in the trial at Royal Adelaide Hospital, with the government hoping to start mass immunisationsAustralia on Wednesday began human trials for a swine flu vaccine as concerns grew over the disease after the global death toll leapt suddenly past 700. Some 240 adults and 400 children are involved in the trial at Royal Adelaide Hospital, with the government hoping to start mass immunisations

Australia starts swine flu vaccine trial as world toll leaps

Australia on Wednesday began human trials for a swine flu vaccine as concerns grew over the disease after the global death toll leapt suddenly past 700.  Some 240 adults and 400 children are involved in the trial at Royal Adelaide Hospital, with the government hoping to start mass immunisationsAustralia on Wednesday began human trials for a swine flu vaccine as concerns grew over the disease after the global death toll leapt suddenly past 700. Some 240 adults and 400 children are involved in the trial at Royal Adelaide Hospital, with the government hoping to start mass immunisations

Mother-of-six among latest flu deaths

A woman who gave birth prematurely and a baby were revealed to be among the latest victims of swine flu as the number of UK deaths from the infection rose sharply.

Ruptara Miah, 39, had used a wheelchair for 15 years after a road accident but had brought up six daughters, relatives said. A statement from Whipps Cross hospital in east London, where she died said: “She was infected with pandemic H1N1. The trust can confirm that she had underlying health conditions.”

Her brother, Abdul Malik said she was admitted to hospital three weeks ago with a cough and chest infection, but her condition worsened and she died without regaining full consciousness. Her son, who was born prematurely, is being treated in an intensive care unit.

The baby who died on July 8 was less than six months old and was being treated at the Royal Free hospital, north London, on 8 July. A 70-year-old man also died at the Royal London hospital on Tuesday and an adult, whose age has not been revealed, died at the city’s St Thomas’ hospital earlier in the month. All the victims, the NHS said, “had serious underlying health conditions”. Tests are also being carried out on a seven-year-old Kent schoolboy who died on Tuesday to see if he had the virus. He suffered from other complications.

Professor Hugh Pennington, a leading microbiologist, yesterday questioned the Department of Health’s projection that as many as 65,000 people could die in the UK from swine flu. Pennington, chairman of an official inquiry into the Scottish E-coli outbreak of 1996, said: “There are all sorts of imponderables, which mean these figures are meaningless.”

He said the attack rate of 30% projected by the DoH was unlikely and he would be “very surprised” if the number of deaths came anywhere close to 65,000. “It would be a fantastically effective virus if it was doing that,” he said. “I’m surprised at the Department of Health putting out these figures in the way they have. I can understand them saying to emergency planners you have to be prepared but why are they going public in what seems like panic mode?”

Doubts over the government’s assertion that a vaccine would be available by the end of next month also surfaced yesterday. The government has ordered 132m doses, sufficient for everyone in the country. “If there is severe disease, countries will want to hang onto the vaccine for their own citizens,” said Michael Osterholm, director of the centre for infectious diseases research and policy at the University of Minnesota. About 70% of the world’s existing flu vaccines are made in Europe. The UK has ordered vaccines from GlaxoSmithKline and Baxter International , which have production plants in Germany, Austria and the Czech Republic.

“Pandemic vaccine will be a valuable and scarce resource, like oil or food during a famine,” said David Fidler, a professor of law at Indiana university who has consulted for the World Health Organisation.

“We’ve seen how countries behave in those situations, and it’s not encouraging.” The Department of Health insisted that its suppliers would honour their contracts.

guardian.co.uk © Guardian News & Media Limited 2009 | Use of this content is subject to our Terms & Conditions | More Feeds


‘This will be our biggest pandemic’

As swine flu sweeps the planet, Margaret Chan, head of the World Health Organisation, tells how she is leading the battle against it – and the personal price she is paying

Although she would no doubt point out that swine flu should properly be called H1N1, there is something pleasing in the fact that the first thing Margaret Chan, director-general of the World Health Organisation, does when I enter her office is pick up a cut-out of a pig that has fallen on its face and carefully place it upright. A pink and gilt confection, it’s left over from celebrating the Chinese year of the pig in 2007: it was so cute, she says, that she couldn’t bear to throw it out.

A year earlier, Chan had been a surprise candidate in a surprise election (the previous incumbent died halfway through his term), but she won with a clear majority to become the first Chinese national to run a major UN agency. A rule change in 2005 (the WHO no longer has to beg states for information about threats to global health, but can just demand it) also makes her the most powerful public health official in history.

Tiny in her orange jacket and neat little orange-brown Miu Miu mules, she wears that authority not lightly, exactly, but naturally: in an organisation famed for its bureaucratic circumlocutions, she is refreshingly direct. It’s a strength she’s aware of – “I have a reputation for being a straight-talker, I will tell them the story like it is” – but that makes it no less striking, or true. (Also striking, for those who have witnessed it, is her penchant for bursting into song: she once punctured a tense moment at a summit about bird flu by singing a few lines of Getting To Know You, from The King and I.)

Months later, on 11 June 2009, she found herself the first WHO chief in 41 years to stand before the world and announce that a new virus had reached pandemic proportions. Right up until the last minute, scientists were calling her up and warning her to be careful about raising the threat alert so high — but the strict definition of “pandemic” is a new disease spreading uncontrollably through numerous countries, and on that count her decision has been completely borne out. On 11 June, swine flu had been registered in 74 countries; when we meet in Geneva four weeks later, it has just been confirmed in 140 countries.

Born in another year of the pig, 62 years ago, Chan began her career as a liberal arts graduate and a high school teacher of home economics, Chinese and English, but when her boyfriend moved to Canada to study medicine, she followed him. Finding that she still saw him very little, she applied to study medicine herself, in the same class. When they graduated they returned to Hong Kong, and in 1994 she was appointed as director of health there, with a staff of 7,000. Three years later, she faced a major outbreak of bird flu.

Chan learned then that clarity of communication is of utmost importance, and that over-reassurance can be as bad as no reassurance at all. She has in mind the (infamous in Hong Kong) moment when she was trying to tell people that it was still safe to eat chicken. “They asked me, ‘Do you eat chicken?’ and I said, ‘Yes, I do. I eat chicken every day.’” It’s the last sentence she regrets, because it is so patently undermining. No one would go on that kind of diet, right?

Her critics were not to know that it was, in fact, true: Chan did eat chicken every day, just as she has had a tuna sandwich every single lunchtime (barring official functions) for the five years she has lived in Geneva. Her job is so big, so unpredictable, that she says these fixed points are crucially important “to maintain my sanity”. So now it’s a tuna sandwich every day, and a session on a treadmill every morning.

But in Hong Kong the damage was done, and she eventually ordered a cull of all 1.5m chickens in the country. By the time the Sars epidemic came round in 2003, she was experienced and tough enough to have earned the nickname “Iron Lady”; although 299 people died in Hong Kong, and she was criticised in some quarters for being slow off the mark (she replied that she had found it hard to get accurate information from mainland China), most experts applauded her efficiency. She was headhunted to improve the WHO’s response to infectious disease threats because, as the then director-general told her, “You are the only person who has managed crises. I have many armchair experts. I need generals.”

Chan’s war has arrived with a vengeance. A 2007 WHO report, A Safer Future, estimated that a flu pandemic could affect more than 1.5 bn people, or 25% of the world’s population. Could swine flu be that big? “Quite likely. Quite likely. But it probably won’t happen in one run. It will probably come back [in two or three waves].”

How does she expect it to compare to other pandemics? “In terms of the number of countries affected and the number of people infected, this has got to be the biggest.”

Bigger than 1918? “If you’re talking about mortality then it’s different. 1918 is the biggest in terms of mortality. I would not like to make any predictions . . . I hope we don’t see the 1918 picture. But we should expect to see more people infected, and more severe cases coming up, including deaths.”

Swine flu is probably already much bigger than anyone knows. Ten days ago, only six countries in Africa had reported cases, but as Chan readily admits, this is rather misleading: until the WHO started sending out lab kits in early May, many developing countries had no means of testing for it. Furthermore, modelling suggests that swine flu has an attack rate of 30% — once it enters a country, the likelihood is 30% of citizens will catch it at some point.

In wealthy countries such as Britain, she observes, “The disease is self-limiting. Some even recover without medicine. But is it going to be the same in a country where they have a high proportion of people suffering from HIV? Or chronic malnutrition? Or diabetes? [all of which damage immune systems]?”

Pregnant women are among the groups most severely affected; already, every minute of every day, a woman dies in childbirth or pregnancy. Furthermore, unlike seasonal flu, H1N1 tends to affect previously healthy 30-50 year-olds; developing countries have large, young populations often living in crowded conditions.

As well as having no testing facilities, these countries will often have almost no access to antivirals such as Tamiflu. “Is it fair,” demands Chan, rhetorically, “for these countries to go into a pandemic empty-handed?” So she has gone, cap in hand, to the companies that produce them: Roche has just provided 5.6m free doses of antivirals, which Chan has dispatched to the developing world; she is angling for another 5-6m, and hopes they will soon come through.

“Vaccines are much more difficult,” she says with some understatement, “because of the limitations in production capacity.” Companies in Europe and North America, and a few small ones in Asia, are racing to make a vaccine to combat this new disease. “One should be available soon, in August. But having a vaccine available is not the same as having a vaccine that is proven safe. Clinical trial data will not be available for another two to three months.”

The process of acquiring a vaccine is already a salutary lesson in health inequality. “Most of the production capacity has already been booked up by wealthy countries. Again I have to ask the question: do the developing countries have to wait at the end of the queue? Because if that’s the case, they won’t have a vaccine for six months.”

So Chan is trying to persuade manufacturers to free up a percentage of their production capacity for developing countries – 10% is her modest request. “The most important thing is to have a supply of vaccine to protect, first and foremost, a functioning health system. It is always important to keep taking care of pregnant women, cancer patients, diabetics and so forth. And I’m also mindful that a certain amount of vaccine should be provided to countries so they can maintain a stable society — that they must vaccinate law enforcement officers, and fire brigades, for example. Making sure that society can function in a normal way.”

There is, of course, the caveat that swine flu has been “mild so far”. Many countries may opt not to vaccinate at all, or not to make it compulsory. But it is also the case that an estimated 250,000-500,000 people die every year from seasonal flu (not including those who die of respiratory failure or heart disease which hasn’t been traced back to an initial flu virus), and that the situation with swine flu could change at any moment. British scientists admitted this week that they were taken by surprise by swine flu’s sudden spread; Chan is aware that while it could work itself out with comparatively minimal damage, she could also suddenly find herself dealing with a far more virulent, more deadly mutation.

And that, of course, would be on top of the myriad other epidemics and crises currently demanding her attention; the massive health impacts of climate change, for example, which she is in no doubt “will be the defining issue of the 21st century”.

Declining food security will, she predicts, mean massive rises in people dying from malnutrition and diarrhoea, and probably more wars. More floods will mean more water contamination and issues with water security, and more deaths due to injuries and drowning. More waterlogged areas and changes in temperature will mean sharp rises in vector-borne diseases such as malaria and dengue fever.

“The prediction is that, within the next 10-20 years, food production in Africa will drop by 50%. If that’s the case, how many more people will go hungry? Remember that malnourished, stunted children cannot reach their education potential, which will have a massive social and economic impact.”

Chan worries, too, about massive rises in non-communicable diseases (cancer, diabetes, smoking-related illnesses) outside their traditional stamping grounds of the well-fed west. The trouble, from her point of view, is that these diseases attract nothing like the funds that, say, malaria or polio or HIV/AIDS do: “60-80% of the disease burden in developing countries is now due to so-called lifestyle diseases” – and yet, until the last two years when the Bloomberg and Gates foundations got in on the act, non-communicable diseases received no donor funds at all.

Then, of course, there are the ongoing battles — malaria (at least seven African regions have reduced deaths by half), polio, measles, HIV and TB, where another crisis of global proportions threatens: “The challenge is drug-resistant TB. And this is really huge. If it gets out of control,” Chan warns, “it will take us back to the pre-antibiotic era.”

And so her days begin at 7am, on her treadmill, and end hunched over her files late at night. Her husband opted not to come with her to Geneva (there would be nothing for him to do, and she travels frequently), so she lives alone in a flat five minutes’ walk away from WHO headquarters. She does not drive, and speaks so little French that when she first came she couldn’t even find a tin-opener in the shops.For 30 years her husband did all the cooking, so she had forgotten how – after a year and a half she fell ill with anaemia. Living apart from him for the first time in 50 years is taking its toll.

“I’m sorry!” she says, flapping her hands helplessly and wiping tears away. “When I talk about my husband . . . you know, he is so interesting, he is such a lovely man. I once said, ‘David, can I have a contract?’ He said, ‘What do you mean?’ I said, ‘Can I marry you again in the next life?’ It’s not easy. But it is the kind of sacrifice I think you have to make in the interests of global health.”

And it is a fixed term; she will be done in another two-and-a-half years. In the meantime, there are aeroplanes. The day after we met, Chan flew to Sharm-el-Sheikh to address the spouses of world leaders on maternal death rates; it was a brief stop on her way home to Hong Kong for a couple of weeks’ annual holiday. Although “with a pandemic,” Chan says wryly, “you can’t really be on leave” •

guardian.co.uk © Guardian News & Media Limited 2009 | Use of this content is subject to our Terms & Conditions | More Feeds


Swine flu vaccine ‘months away’

Head of World Health Organisation casts doubt on government’s claim that first stocks will arrive in August

Vaccines to protect millions of Britons from swine flu will not be available for several months, the head of the World Health Organisation warns today.

Her remarks, in an interview with the Guardian, cast serious doubt on ministerial claims in parliament that the first stocks would arrive in August.

Dr Margaret Chan, WHO director general, said: “There’s no vaccine. One should be available soon, in August. But having a vaccine available is not the same as having a vaccine that has been proven safe. Clinical trial data will not be available for another two to three months.”

One of the world’s most respected influenza scientists told the Guardian that health officials have been surprised by the rapid spread of swine flu in the UK. Dr Alan Hay, director of the WHO’s London-based World Influenza Centre, said the extensive summer outbreak in Britain had not followed expected patterns and warned that the health department needed to be prepared for a more deadly form of the disease.

“We have been a little surprised by the degree of spread of this virus. A few weeks ago we anticipated that this was going to be a short series of outbreaks that would probably peter out before reappearing in the autumn or winter and that has proved not to be the case,” he said.

He said Burnham had been “a bit optimistic” when he told the House of Commons that a flu vaccine would arrive in Britain next month.

Public anxiety about swine flu has risen since the death of six-year-old north-west London schoolgirl Chloe Buckley, who had contracted the virus but had previously apparently enjoyed good health. Sixteen people in the UK have now died after contracting swine flu – although a postmortem revealed yesterday that Bedfordshire GP Dr Michael Day, who was thought to have become the 17th victim, had died as a result of natural causes.

At least 335 people have been treated in hospital after contracting the virus, but tens of thousands are visiting GPs with flu-like symptoms every week, according to the Health Protection Agency.

Andy Burnham, the health secretary, urged people yesterday to keep the threat posed by swine flu “in perspective”, noting the vast majority of sufferers made a full recovery. Britain was “front of the queue” for vaccine stocks, he told GMTV.

But while it is known that the government asked two major drug companies in June to urgently develop a vaccine, trials of preliminary batches of what they hope will be an effective jab have only begun in the last fortnight. A Department of Health spokeswoman said: “We expect delivery of the vaccine in the coming months. Vaccine development can take some time. We hope to have enough vaccine by the end of the year to cover half of the population, but that’s a forecast and it could go up or it could decrease. We can’t be more precise about when it will be delivered and go into people’s arms.”

The government is basing its contingency planning on the UK workforce being reduced by 15-20% at the pandemic’s peak. That could rise to 35% in the unlikely event that every school closed.

The plans are based on the expectation of a 15-week-long wave of illness, but it is impossible to predict how many there will be.

Latest swine flu developments were discussed at cabinet level yesterday. Part of the government’s strategy will see the NHS cancel non-emergency operations, discharge patients early and care for people with swine flu miles away from their homes if hospitals become overwhelmed with people who are seriously ill with the virus.

The Department of Health has agreed the contingency measures with local NHS leaders during co-ordinated efforts intended to help them prepare to cope with a possible huge increase in the number of people who need what would in some cases be life-saving treatment.

Operations involving elective or non-urgent surgery for conditions such as a hernia or varicose veins would be halted and beds earmarked for these patients used instead for people whose health is at risk because they have swine flu as well as breathing conditions such as asthma, bronchitis or pneumonia.

Hospitals in swine flu hotspots such as London and the West Midlands that become overwhelmed by the sheer number of patients have also put in place plans to transfer some such cases to nearby hospitals, some of which could be 10 or 20 miles away.

guardian.co.uk © Guardian News & Media Limited 2009 | Use of this content is subject to our Terms & Conditions | More Feeds


WHO: Swine flu virus is “unstoppable”

A top World Health Organization official says the H1N1 swine flu virus is “unstoppable” and says every country needs the vaccine.
WHO vaccine research chief Marie-Paule Kieny said Monday that health care workers should get immunized first because they are needed during an outbreak.

Swine flu pandemic is ‘unstoppable’, says WHO official

With 12 new deaths owing to swine flu being reported, a World Health Organisation (WHO) official has said that the deadly pandemic has become “unstoppable”, and all nations need an immediate access to vaccines.
Britain, Brazil, Colombia, Mexico, the Philippines, and Thailand all reported deaths on July 13, while Saudi Arabia shut an international school after [...]

WHO says health workers priority for H1N1 vaccine

Healthcare workers should get priority access to H1N1 flu vaccinations but individual countries should decide who would be next in line for the vaccine, the World Health Organisation said on Monday. Marie-Paule Kieny, WHO director of the Initiative for Vaccine Research, also said